Lysophosphatidic acid and ovarian cancer: A paradigm for tumorogenesis and patient management

James R. Erickson; Yutaka Hasegawa; Xianjun Fang; Astrid Eder; Muling Mao; Tatsuro Furui; Junken Aoki; Andrew Morris; Gordon B. Mills

doi:10.1016/S0090-6980(01)00100-9

Lysophosphatidic acid and ovarian cancer: A paradigm for tumorogenesis and patient management

James R. Erickson
, Yutaka Hasegawa
, Xianjun Fang
, Astrid Eder
, Muling Mao
, Tatsuro Furui
, Junken Aoki
, Andrew Morris
, Gordon B. Mills

Internal Medicine

Producción científica: Article › revisión exhaustiva

28 Citas (Scopus)

Idioma original	English
Páginas (desde-hasta)	63-81
Número de páginas	19
Publicación	Prostaglandins and Other Lipid Mediators
Volumen	64
N.º	1-4
DOI	https://doi.org/10.1016/S0090-6980(01)00100-9
Estado	Published - abr 2001

ODS de las Naciones Unidas

Este resultado contribuye a los siguientes Objetivos de Desarrollo Sostenible

Good health and well being

ASJC Scopus subject areas

Biochemistry
Physiology
Pharmacology
Cell Biology

Acceder al documento

10.1016/S0090-6980(01)00100-9

Otros archivos y enlaces

Citar esto

@article{0fd09dbff2ed42e8861c67909085f332,

title = "Lysophosphatidic acid and ovarian cancer: A paradigm for tumorogenesis and patient management",

keywords = "Diagnostics, Edg receptor, Lipase PCR, Lysophosphatidic acid, Ovarian cancer, Sphingosine-1-phosphate, Therapeutics, Tumour markers",

author = "Erickson, \{James R.\} and Yutaka Hasegawa and Xianjun Fang and Astrid Eder and Muling Mao and Tatsuro Furui and Junken Aoki and Andrew Morris and Mills, \{Gordon B.\}",

year = "2001",

month = apr,

doi = "10.1016/S0090-6980(01)00100-9",

language = "English",

volume = "64",

pages = "63--81",

number = "1-4",

}

TY - JOUR

T1 - Lysophosphatidic acid and ovarian cancer

T2 - A paradigm for tumorogenesis and patient management

AU - Erickson, James R.

AU - Hasegawa, Yutaka

AU - Fang, Xianjun

AU - Eder, Astrid

AU - Mao, Muling

AU - Furui, Tatsuro

AU - Aoki, Junken

AU - Morris, Andrew

AU - Mills, Gordon B.

PY - 2001/4

Y1 - 2001/4

KW - Diagnostics

KW - Edg receptor

KW - Lipase PCR

KW - Lysophosphatidic acid

KW - Ovarian cancer

KW - Sphingosine-1-phosphate

KW - Therapeutics

KW - Tumour markers

UR - https://www.scopus.com/pages/publications/0035021984

UR - https://www.scopus.com/pages/publications/0035021984#tab=citedBy

U2 - 10.1016/S0090-6980(01)00100-9

DO - 10.1016/S0090-6980(01)00100-9

M3 - Article

C2 - 11324708

AN - SCOPUS:0035021984

SN - 0090-6980

VL - 64

SP - 63

EP - 81

JO - Prostaglandins and Other Lipid Mediators

JF - Prostaglandins and Other Lipid Mediators

IS - 1-4

ER -

Lysophosphatidic acid and ovarian cancer: A paradigm for tumorogenesis and patient management

ODS de las Naciones Unidas

ASJC Scopus subject areas

Acceder al documento

Otros archivos y enlaces

Huella

Citar esto